HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
3.270
-0.140 (-4.11%)
At close: Aug 10, 2026, 4:00 PM EDT
3.340
+0.070 (2.14%)
After-hours: Aug 10, 2026, 7:18 PM EDT
HCW Biologics Revenue
HCW Biologics had revenue of $6.54M in the quarter ending March 31, 2026, with 129,080.67% growth. This brings the company's revenue in the last twelve months to $6.59M, up 356.16% year-over-year. In the year 2025, HCW Biologics had annual revenue of $54.23K, down -97.89%.
Revenue (ttm)
$6.59M
Revenue Growth
+356.16%
P/S Ratio
0.65
Revenue / Employee
$188,348
Employees
35
Market Cap
3.90M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 54.23K | -2.51M | -97.89% |
| Dec 31, 2024 | 2.57M | -275.00K | -9.68% |
| Dec 31, 2023 | 2.84M | -3.88M | -57.72% |
| Dec 31, 2022 | 6.72M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PMGC Holdings | 1.27M |
| SciSparc | 856.00K |
| Onconetix | 735.20K |
| Silo Pharma | 72.10K |
| Creative Medical Technology Holdings | 3.00K |
| Alaunos Therapeutics | 3.00K |
HCWB News
- 12 days ago - HCW Biologics announces pricing of $1.6M private placement - TheFly
- 12 days ago - HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering - GlobeNewsWire
- 18 days ago - HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027 - GlobeNewsWire
- 5 weeks ago - HCW Biologics regains compliance with Nasdaq - TheFly
- 5 weeks ago - HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter - GlobeNewsWire
- 6 weeks ago - Hcw Biologics Inc trading halted, news pending - TheFly
- 6 weeks ago - HCW Biologics announces 1-for-6 reverse stock split - TheFly
- 6 weeks ago - HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026 - GlobeNewsWire